01 20ARIPIPRAZOLE
02 6BREXPIPRAZOLE
03 2CILOSTAZOL
04 1DECITABINE
05 1FERRIC AMMONIUM CITRATE
06 3GREPAFLOXACIN HYDROCHLORIDE
07 8TOLVAPTAN
01 41OTSUKA
01 1FOR SOLUTION;ORAL
02 1INJECTABLE;INTRAMUSCULAR
03 1INJECTABLE;INTRAVENOUS
04 1SOLUTION;ORAL
05 2SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
06 4TABLET, ORALLY DISINTEGRATING;ORAL
07 31TABLET;ORAL
01 10.25MG
02 10.5MG
03 1100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
04 210MG
05 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
06 415MG
07 115MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
08 11MG
09 11MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
10 220MG
11 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
12 32MG
13 430MG
14 130MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
15 13MG
16 145MG
17 14MG
18 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
19 150MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
20 25MG
21 1600MG/PACKET
22 160MG
23 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
24 1720MG/2.4ML (300MG/ML)
25 19.75MG/1.3ML (7.5MG/ML)
26 190MG
27 1960MG/3.2ML (300MG/ML)
28 1EQ 200MG BASE
29 1EQ 400MG BASE
30 1EQ 600MG BASE
01 41USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ABILIFY
Dosage Strength : 20MG
Packaging :
Approval Date : 2002-11-15
Application Number : 21436
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ABILIFY
Dosage Strength : 5MG
Packaging :
Approval Date : 2002-11-15
Application Number : 21436
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : SOLUTION;ORAL
Brand Name : ABILIFY
Dosage Strength : 1MG/ML **Federal Regis...
Packaging :
Approval Date : 2004-12-10
Application Number : 21713
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET, ORALLY DISINTEGR...
Brand Name : ABILIFY
Dosage Strength : 20MG **Federal Registe...
Packaging :
Approval Date : 2006-06-07
Application Number : 21729
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET, ORALLY DISINTEGR...
Brand Name : ABILIFY
Dosage Strength : 30MG **Federal Registe...
Packaging :
Approval Date : 2006-06-07
Application Number : 21729
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : INJECTABLE;INTRAMUSCULAR
Brand Name : ABILIFY
Dosage Strength : 9.75MG/1.3ML (7.5MG/ML...
Packaging :
Approval Date : 2006-09-20
Application Number : 21866
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ABILIFY MYCITE KIT
Dosage Strength : 2MG
Packaging :
Approval Date : 2017-11-13
Application Number : 207202
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ABILIFY MYCITE KIT
Dosage Strength : 10MG
Packaging :
Approval Date : 2017-11-13
Application Number : 207202
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ABILIFY MYCITE KIT
Dosage Strength : 30MG
Packaging :
Approval Date : 2017-11-13
Application Number : 207202
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : SUSPENSION, EXTENDED REL...
Brand Name : ABILIFY ASIMTUFII
Dosage Strength : 960MG/3.2ML (300MG/ML)
Packaging :
Approval Date : 2023-04-27
Application Number : 217006
Regulatory Info : RX
Registration Country : USA
Otsuka Chemical Co Ltd is a supplier offers 13 products (APIs, Excipients or Intermediates).
Find a price of Tazobactam Sodium bulk with DMF, JDMF offered by Otsuka Chemical Co Ltd
Find a price of (4-Methoxyphenyl)Methyl (6R,7R)-3-(Chloromethyl)-8-Oxo-7-(2-Phenylacetamido)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylate bulk with DMF offered by Otsuka Chemical Co Ltd
Find a price of Carteolol bulk offered by Otsuka Chemical Co Ltd
Find a price of Gcle:Intermediate For Cephalosporin bulk offered by Otsuka Chemical Co Ltd
Find a price of Lipoprotein Lipase Activator bulk offered by Otsuka Chemical Co Ltd
Find a price of Nadifloxacin bulk offered by Otsuka Chemical Co Ltd
Find a price of Procaterol bulk offered by Otsuka Chemical Co Ltd
Find a price of Rebamipide bulk offered by Otsuka Chemical Co Ltd
Find a price of Water bulk offered by Otsuka Chemical Co Ltd
Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN TOKUSHIMA, JAPAN. bulk offered by Otsuka Chemical Co Ltd
Find a price of FORMULATION RESEARCH INSTITUTE IN TOKUSHIMA, JAPAN bulk offered by Otsuka Chemical Co Ltd
Find a price of COMMERCIAL BULK PLANT OF SECOND TOKUSHIMA FACTORY IN TOKUSHIMA, JAPAN bulk offered by Otsuka Chemical Co Ltd
Find a price of FACILITIES AND OPERATING PROCEDURES AT THE SAGA FACTORY, JAPAN bulk offered by Otsuka Chemical Co Ltd
